Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

Kevin H.M. Kuo, Sylvia Titi Singer, Gershwin Theophilus Blyden, Lanetta Bronté-Hall, Aidan Faller, Abdullah Kutlar, Frans A. Kuypers, Aliya U. Zaidi, Patrick C. Hines, Niren Patel, Sandra Larkin, Hanny Al-Samkari, Sujit Sheth, Seyed Mehdi Nouraie, Susan Perrine

Blood (2023) 142 (Supplement 1): 1148.

https://doi.org/10.1182/blood-2023-184627

Published: 2023

Journal Articles

The Effect of Short-Term Simvastatin On Markers of Vascular Dysfunction in Patients with Sickle Cell Disease (SCD).

Carolyn C. Hoppe, M.D., Kathryn R. Stewart, B.S., Annie Higa, B.S., Sandra Larkin, B.S., James K. Liao, M.D., Lori A. Styles, M.D., Elliott P. Vichinsky, M.D., Frans A. Kuypers, Ph.D.

Blood (2009) 114 (22): 260.

https://doi.org/10.1182/blood.V114.22.260.260

Published: 2009

Journal Articles

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Claudia R. Morris, Jung H. Suh, Ward Hagar, Sandra Larkin, D. Anton Bland, Martin H. Steinberg, Elliott P. Vichinsky, Mark Shigenaga, Bruce Ames, Frans A. Kuypers, Elizabeth S. Klings

Blood (2008) 111 (1): 402–410.

https://doi.org/10.1182/blood-2007-04-081703

Published: 2008

Includes: Supplemental data

Journal Articles

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Claudia R. Morris, MD, Jung Suh, PhD, Ward Hagar, MD, Sandra Larkin, D. Anton Bland, Martin Steinberg, MD, Elliott Vichinsky, Mark Shigenaga, PhD, Bruce Ames, PhD, Frans Kuypers, PhD, Elizabeth Klings, MD

Blood (2007) 110 (11): 2257.

https://doi.org/10.1182/blood.V110.11.2257.2257

Published: 2007

Journal Articles

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Claudia R. Morris, MD, Jung H. Suh, PhD, Sandra Larkin, MS, D. Anton Bland, BS, Adam Odhiambo, BS, Martin H. Steinberg, MD, Elliott P. Vichinsky, MD, Mark Shigenaga, PhD, Bruce Ames, PhD, Frans A. Kuypers, PhD, Elizabeth S. Klings, MD

Blood (2006) 108 (11): 788.

https://doi.org/10.1182/blood.V108.11.788.788

Published: 2006

Journal Articles

Red Blood Cells Facilitate Reverse Cholesterol Transport.

Frans A. Kuypers, PhD, Sandra Larkin, MS, Jenifer Beckstead, Michael Oda, PhD, Kazumitsu Ueda, PhD, Robert O. Ryan, PhD

Blood (2004) 104 (11): 1589.

https://doi.org/10.1182/blood.V104.11.1589.1589

Published: 2004

NARROW

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

The Effect of Short-Term Simvastatin On Markers of Vascular Dysfunction in Patients with Sickle Cell Disease (SCD).

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Red Blood Cells Facilitate Reverse Cholesterol Transport.

Email alerts

ASH Publications

American Society of Hematology

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

The Effect of Short-Term Simvastatin On Markers of Vascular Dysfunction in Patients with Sickle Cell Disease (SCD).

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Red Blood Cells Facilitate Reverse Cholesterol Transport.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only